跳至主要内容
临床试验/NCT00566514
NCT00566514暂停不适用

The Role of D-RIbose in Patients Diagnosed With Fibromyalgia

Bioenergy Life Science, Inc.2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2006年7月最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
入组人数
200
试验地点
2
主要终点
Significant reduction in symptoms of pain and fatigue

研究概览

简要总结

The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.

详细描述

Two hundred to three hundred subjects (equally distribued between placebo and D-ribose) between 18-78 years of age will comprise this study. The final numbers enrolled will depend upon obtaining approximately 100 subjects that can display a high degree of compliance to TID dosing with approximately equal balance between the active and placebo arms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 78 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • previous diagnosis of fibromomyalgia by a MD
  • Has been diagnosed with fibromyalgia and are over 18 years of age
  • Does live in the United States

排除标准

  • does NOT have severe medication/chemical/supplement sensitivities
  • does NOT have insulin dependent diabetes or other severe illnesses (cancer, hepatitis, congestive heart failure)
  • does NOT have rheumatoid arthritis or gout
  • previous use of ribose

结局指标

主要结局

Significant reduction in symptoms of pain and fatigue

时间窗: 3 weeks

次要结局

  • Demonstrate an improvement in ones quality of life(3 weeks)

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

The Role of Ribose in Patients Diagnosed With... | 临床试验